The Rilpivirine Cerebrospinal-fluid (CSF) Study

This study is currently recruiting participants.
Verified March 2012 by Imperial College London
Sponsor:
Collaborator:
Janssen-Cilag Ltd.
Information provided by (Responsible Party):
Imperial College London
ClinicalTrials.gov Identifier:
NCT01562886
First received: March 22, 2012
Last updated: March 23, 2012
Last verified: March 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2013
  Estimated Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)